ZJYL vs LFUS vs MPWR vs CTS

For growth investors, Monolithic Power Systems, Inc.

(MPWR) is the stronger pick with 26. 4% revenue growth year-over-year, versus 5. 2% for CTS Corporation (CTS). CTS Corporation (CTS) offers the better valuation at 27. 3x trailing P/E (24. 6x forward), making it the more compelling value choice. Analysts rate Littelfuse, Inc. (LFUS) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, CTS Corporation (CTS) is the cheapest at 27.

3x versus Monolithic Power Systems, Inc. at 123. 6x. On forward P/E, CTS Corporation is actually cheaper at 24. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: CTS Corporation wins at 1. 58x versus Monolithic Power Systems, Inc. 's 2. 48x — a reasonable growth-adjusted valuation.

Over the past 5 years, Monolithic Power Systems, Inc.

(MPWR) delivered a total return of +366. 2%, compared to -72. 3% for Jin Medical International Ltd. (ZJYL). Over 10 years, the gap is even starker: MPWR returned +24. 9% versus ZJYL's -72. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), CTS Corporation (CTS) is the lower-risk stock at 1.

44β versus Monolithic Power Systems, Inc. 's 2. 28β — meaning MPWR is approximately 58% more volatile than CTS relative to the S&P 500. On balance sheet safety, Monolithic Power Systems, Inc. (MPWR) carries a lower debt/equity ratio of 1% versus 41% for Jin Medical International Ltd. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Monolithic Power Systems, Inc.

(MPWR) is pulling ahead at 26. 4% versus 5. 2% for CTS Corporation (CTS). On earnings-per-share growth, the picture is similar: Jin Medical International Ltd. grew EPS 18. 7% year-over-year, compared to -172. 5% for Littelfuse, Inc.. Over a 3-year CAGR, MPWR leads at 15. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Monolithic Power Systems, Inc.

(MPWR) is the more profitable company, earning 22. 1% net margin versus -3. 0% for Littelfuse, Inc. — meaning it keeps 22. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MPWR leads at 26. 1% versus 1. 6% for LFUS. At the gross margin level — before operating expenses — MPWR leads at 55. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, CTS Corporation (CTS) is the more undervalued stock at a PEG of 1. 58x versus Monolithic Power Systems, Inc. 's 2. 48x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, CTS Corporation (CTS) trades at 24. 6x forward P/E versus 73. 1x for Monolithic Power Systems, Inc. — 48. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MPWR: 2. 5% to $1615. 00.

In this comparison, LFUS (0.

7% yield), MPWR (0. 4% yield), CTS (0. 3% yield) pay a dividend. ZJYL does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Littelfuse, Inc.

(LFUS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (0. 7% yield, +317. 6% 10Y return). Monolithic Power Systems, Inc. (MPWR) carries a higher beta of 2. 28 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (LFUS: +317. 6%, MPWR: +24. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (ZJYL (Healthcare) and LFUS (Technology) and MPWR (Technology) and CTS (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: ZJYL is a small-cap high-growth stock; LFUS is a mid-cap quality compounder stock; MPWR is a mid-cap high-growth stock; CTS is a small-cap quality compounder stock. LFUS pays a dividend while ZJYL, MPWR, CTS do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.